Chemotherapy-induced cardiotoxicity: Role of the conventional echocardiography and the tissue Doppler

Minerva Cardioangiologica

Volumn 59, Issue 4, 2011, Pages 301-308

  Di Lisi, D ^a   Bonura, F ^a   Macaione, F ^a   Cuttitta, F ^a   Peritore, A ^a   Meschisi, M ^a   Novo, G ^a   D'Alessandro, N ^a   Novo, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Drug therapy; Drug toxicity; Medical oncology ultrasonography, Doppler

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; SARTAN DERIVATIVE; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CARDIOTOXICITY; CONTROLLED STUDY; CONVENTIONAL ECHOCARDIOGRAPHY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HEART VENTRICLE EJECTION TIME; HUMAN; HYPERTENSION; ISOVOLUMIC CONTRACTION TIME; ISOVOLUMIC RELAXATION TIME; MAJOR CLINICAL STUDY; MITRAL ANNULAR PLANE SYSTOLIC EXCURSION; MYOCARDIAL ATRIAL VELOCITY; MYOCARDIAL EARLY DIASTOLIC VELOCITY; MYOCARDIAL PERFORMANCE INDEX; MYOCARDIAL SYSTOLIC VELOCITY; PROSPECTIVE STUDY; SIDE EFFECT; SUPRAVENTRICULAR PREMATURE BEAT; TISSUE DOPPLER IMAGING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 80054762037     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Boccardi L, Minardi G. Cardiac management in women receiving chemioterapy for breast cancer. Annali degli ospedali San Camillo e Forlanini Roma 2010;12:10-42.
2. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007;50:1435-41 (Pubitemid 47494586)
3. Burstein HB, Winer EP. Primary Care for survivors of breast cancer. N Engl J Med 2000;343:1086-109.
4. Albini A, Pennesi G, Donatelli F, Donatelli F, Cammarota R, De Flora S et al. Cardiotoxicity of anticancer drugs:the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 2010;102:14-25.
5. Pai VB, Nahata MC. Cardiotoxicity of chemiotherapeutic agents:incidence, treatment and prevention. Drug Safety 2000;22:263-302. (Pubitemid 30213944)
6. Barret- Lee PJ, Dixon JM, Farrell C, Jones A, Leonard R, Murray N et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol 2009;20:816-27.
7. Suter T, Procter M, van Veldhuisen D, van Veldhuisen J, Muscholl M, Bergh J et al. Trastuzumab-associated cardiac adverse effects in the Herceptin adjuvant trial. JCO 2007;25:3859-65. (Pubitemid 47477261)
8. Edward T, Lenihan D, Swafford J, Tong A, Yusuf W, Champion C et al. Cardiovascular complications of cancer therapy. Diagnosis, pathogenesis and management. Circulation 2004;109:3122-31.
9. Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT et al. Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev 1999;25:237-47. (Pubitemid 29417681)
10. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N England J Med 1998;339:900-5. (Pubitemid 28446849)
11. Pai RG, Kos JH, Adamick RD. Usefulness of systolic excursion of mitral annulus as an index of left ventricular systolic function. Am J Cardiol 1991;67:222-4.
12. Cardinale D, Sandri MT, Martinoni A, Borghini E, Civelli M, Lamantia G et al. Myocardial injury revealed by plasma troponin I in breast cancer treated with high dose chemotherapy. Ann Oncol 2002;13:710-5. (Pubitemid 34567376)
13. Jurcut R, Ganame J, Wildiers H, Ganame J, D'hooge J, Paridaens R et al. Detection and monitoring of cardiotoxicity- what does modern cardiology offer? Support Care Cancer 2008;16:437-45.
14. Sohn D, Chai I, Lee D, Kim H, Oh B, Lee M et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80. (Pubitemid 27339328)
15. Kaul S, Tei C, Hopkins J, Shah P. Assesment of right ventricular function using two dimensional echocardiography. Am Heart J 1984;107:526-31. (Pubitemid 14167729)
16. Vizzardi E, Faggiano P, Maffeo D, Chiari E, Frattini S, Bellandi F et al. The study of left ventricular diastolic function by Doppler echocardiography: the essential for the clinician. Monaldi Arch Chest Dis 2009;72:23-8.
17. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging:a non invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33. (Pubitemid 27486472)
18. Galderisi M, Nistri S, Ansalone G, Di Salvo G, Dini FL, Gallina S et al. Il Doppler tissutale pulsato illustrato ad uno specializzando in cardiologia. G Ital Cardiol 2007;8:92-102.
19. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al. New index of combined systolic and diastolic myocardial performance:a simple and reproducible measure of cardiac function- a study in normals and dilated cardiomiopathy. J Cardiol 1995;26:357-66. (Pubitemid 26011184)
20. Sereno M, Brunello A, Chiappori A, Barriuso J, Casado E, Belda C et al. Cardiac Toxicity:old and new issues in anti-cancer drugs. Clin Transl Oncol 2008;10:35-46.
21. Cardinale D, Colombo A, Sandri M, Lamantia G, Colombo N, Civelli M et al. Prevention of high-dose chemiotherapy-induced cardiotoxicity in high risk patients by Angiotensin- converting enzyme inhibition. Circulation 2006;114:2474-81. (Pubitemid 44901520)
22. Vaynblat M, Shah HR. Bhaskaran D, Ramdev G, Davis WJ, Cunningham JN et al. Simultaneous angiotensin converting enzyme inhibition moderates ventricular dysfunction caused by doxorubicin. Eur J Heart Fail 2002;4:583-6. (Pubitemid 35278509)
23. Tallaj JA, Franco V, Rayburn BK, Pinderski L, Benza RL, Pamboukian S et al. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure. J Heart Lung Transplant 2005;24:2196-201. (Pubitemid 41814746)
24. Boccardi L, Minardi G. Cardiac management in women receiving chemioterapy for breast cancer. Annali degli ospedali San Camillo e Forlanini Roma 2010;12:10-42.